Brief: Elekta Evo Submitted To U.S. FDA For Premarket Approval
Sept 24 (Reuters) - Elekta AB (publ) EKTAb.ST :
* ELEKTA EVO SUBMITTED TO U.S. FDA FOR PREMARKET APPROVAL –
TO BE
FEATURED AT ASTRO
Source text for Eikon: ID:nMFN23wkl1
Further company coverage: EKTAb.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))